Meeting
2023 ASCO Genitourinary Cancers Symposium
Validation of baseline health-related quality of life as prognostic indicator for survival outcome in men with intermediate risk prostate cancer undergoing radical prostatectomy.
Authors
Thilo Westhofen
Department of Urology, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany
Thilo Westhofen , Alexander Buchner , Boris Schlenker , Armin Becker , Christian G. Stief , Alexander Kretschmer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 340)
DOI
10.1200/JCO.2023.41.6_suppl.340
Abstract #
340
Poster Bd #
L18
Abstract Disclosures
Similar Posters
Poster
2015 Genitourinary Cancers Symposium
Does the extent of pelvic lymph node dissection affect long-term survival in men undergoing radical prostatectomy after radiation for adenocarcinoma of the prostate?
First Author: Danny Long Huynh
Poster
2023 ASCO Breakthrough
Patterns of failure in nasopharyngeal cancer patients of northeastern region of India.
First Author: Prashasti Sharma
Poster
2023 ASCO Genitourinary Cancers Symposium
Use of prostate cancer subtyping by gene expression to predict response to radiation and chemohormonal therapies.
First Author: Adam B Weiner
Poster
2021 Genitourinary Cancers Symposium
Adverse pathology as a predictor of distant metastasis and prostate cancer mortality with 20-year follow up.
First Author: Michael Austin Brooks